Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingjing Lv

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Journal of Biomaterials Applications|July 26, 2015
Constitution and in vivo test of micro-porous tubular scaffold for esophageal tissue engineeringLei Hou, Jiachang Jin, Jingjing Lv, et al.
Respiratory Care|March 28, 2013
Laboratory test of a visual sputum suctioning systemJingjing Lv, Jingxing Wu, Rui Guo, et al.
Plos One|September 17, 2020
Prediction of hepatitis E using machine learning modelsYanhui Guo, Yi Feng, Fuli Qu, et al.
American Journal of Translational Research|June 21, 2019
A novel human-derived tissue-engineered patch for vascular reconstructionLiping Gao, Tianming Shi, Zhenhua Wang, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
The Preparation of N-Doped Titanium Dioxide Films and Their Degradation of Organic PollutantsYanyan Dou, Yixuan Chang, Xuejun Duan, et al.
International Journal of Food Microbiology|May 23, 2026
Hepatitis E virus infection among raw pork products, pig feces, and human cases in Shandong Province, China: A prospective cross-sectional molecular studyXiaotian Zhu, Jingjing Lv, Yi Feng, et al.
Scientific Reports|July 29, 2017
Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern ChinaBingyu Yan, Jingjing Lv, Yi Feng, et al.
Vaccine|March 18, 2018
Antibody response to hepatitis B vaccine is independently associated with hepatitis B breakthrough infection among adults: Results from a three-year follow-up study in ChinaLi Zhang, Bingyu Yan, Jingjing Lv, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progressLi Zhang, Stephen Ko, Jingjing Lv, et al.
Human Vaccines & Immunotherapeutics|July 12, 2018
Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: Results from a five-year follow-up study in ChinaWenlong Wu, Jingjing Lv, Jiaye Liu, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Journal of Biomaterials Applications|July 26, 2015
Constitution and in vivo test of micro-porous tubular scaffold for esophageal tissue engineeringLei Hou, Jiachang Jin, Jingjing Lv, et al.
Respiratory Care|March 28, 2013
Laboratory test of a visual sputum suctioning systemJingjing Lv, Jingxing Wu, Rui Guo, et al.
Plos One|September 17, 2020
Prediction of hepatitis E using machine learning modelsYanhui Guo, Yi Feng, Fuli Qu, et al.
American Journal of Translational Research|June 21, 2019
A novel human-derived tissue-engineered patch for vascular reconstructionLiping Gao, Tianming Shi, Zhenhua Wang, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
The Preparation of N-Doped Titanium Dioxide Films and Their Degradation of Organic PollutantsYanyan Dou, Yixuan Chang, Xuejun Duan, et al.
International Journal of Food Microbiology|May 23, 2026
Hepatitis E virus infection among raw pork products, pig feces, and human cases in Shandong Province, China: A prospective cross-sectional molecular studyXiaotian Zhu, Jingjing Lv, Yi Feng, et al.
Scientific Reports|July 29, 2017
Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern ChinaBingyu Yan, Jingjing Lv, Yi Feng, et al.
Vaccine|March 18, 2018
Antibody response to hepatitis B vaccine is independently associated with hepatitis B breakthrough infection among adults: Results from a three-year follow-up study in ChinaLi Zhang, Bingyu Yan, Jingjing Lv, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progressLi Zhang, Stephen Ko, Jingjing Lv, et al.
Human Vaccines & Immunotherapeutics|July 12, 2018
Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: Results from a five-year follow-up study in ChinaWenlong Wu, Jingjing Lv, Jiaye Liu, et al.
Pageof 8